Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Frontiers in Neurology
|
December 30, 2021
Basilar Artery Dolichosis Increases the Risk of Long-Term Recurrence in Patients With Pontine Infarction: A Prospective Cohort Study
Shugang Cao, Xiaoxia Zhu, Qian Wu, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
December 23, 2022
Basilar artery curvature increases the risk of posterior circulation infarction occurrence in patients without vertebrobasilar stenosis
Shugang Cao, Mingfeng Zhai, Jun He, et al.
Journal of Neurology
|
May 18, 2025
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD
Shugang Cao, Xingyue Zhou, Jing Du, et al.
Multiple Sclerosis and Related Disorders
|
January 26, 2023
B-cell proliferation characteristics and monitoring significance under the modified reduced-dose rituximab regimen for NMOSD: A real-world case series study
Shugang Cao, Xiaoyuan Wang, Xiaopei Ji, et al.
Brain and Behavior
|
February 21, 2024
Correlation of GABA<sup>+</sup> levels in the medial prefrontal cortex and circulating follicular helper T cells in neuromyelitis optica spectrum disorder patients with cognitive impairment
Yinghui Duan, Qianyun Rui, Yang Yang, et al.
Neurotoxicity Research
|
April 25, 2022
Depletion of B7-H4 from C3H10 T1/2 Mesenchymal Stem Cells Attenuates their Immunomodulatory Therapy in Experimental Autoimmune Encephalomyelitis Mice
Hao Li, Simao Sun, Zhou Yin, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
August 28, 2020
A randomized Phase I pharmacokinetic trial comparing the potential biosimilar trastuzumab (SIBP-01) with the reference product (Herceptin®) in healthy Chinese male volunteers
Huan Zhou, Shugang Cao, Xingyu Zhu, et al.
Journal of the Neurological Sciences
|
August 27, 2021
Efficacy and safety of modified reduced-dose rituximab in Chinese patients with neuromyelitis optica spectrum disorder: A retrospective cohort study
Shugang Cao, Hai Yu, Jingluan Tian, et al.
Clinical Pharmacology in Drug Development
|
July 18, 2022
Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B-Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein, in Healthy Chinese Subjects
Jing Xie, Xiaoyun Fan, Yue Su, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Frontiers in Neurology
|
December 30, 2021
Basilar Artery Dolichosis Increases the Risk of Long-Term Recurrence in Patients With Pontine Infarction: A Prospective Cohort Study
Shugang Cao, Xiaoxia Zhu, Qian Wu, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
December 23, 2022
Basilar artery curvature increases the risk of posterior circulation infarction occurrence in patients without vertebrobasilar stenosis
Shugang Cao, Mingfeng Zhai, Jun He, et al.
Journal of Neurology
|
May 18, 2025
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD
Shugang Cao, Xingyue Zhou, Jing Du, et al.
Multiple Sclerosis and Related Disorders
|
January 26, 2023
B-cell proliferation characteristics and monitoring significance under the modified reduced-dose rituximab regimen for NMOSD: A real-world case series study
Shugang Cao, Xiaoyuan Wang, Xiaopei Ji, et al.
Brain and Behavior
|
February 21, 2024
Correlation of GABA<sup>+</sup> levels in the medial prefrontal cortex and circulating follicular helper T cells in neuromyelitis optica spectrum disorder patients with cognitive impairment
Yinghui Duan, Qianyun Rui, Yang Yang, et al.
Neurotoxicity Research
|
April 25, 2022
Depletion of B7-H4 from C3H10 T1/2 Mesenchymal Stem Cells Attenuates their Immunomodulatory Therapy in Experimental Autoimmune Encephalomyelitis Mice
Hao Li, Simao Sun, Zhou Yin, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
August 28, 2020
A randomized Phase I pharmacokinetic trial comparing the potential biosimilar trastuzumab (SIBP-01) with the reference product (Herceptin®) in healthy Chinese male volunteers
Huan Zhou, Shugang Cao, Xingyu Zhu, et al.
Journal of the Neurological Sciences
|
August 27, 2021
Efficacy and safety of modified reduced-dose rituximab in Chinese patients with neuromyelitis optica spectrum disorder: A retrospective cohort study
Shugang Cao, Hai Yu, Jingluan Tian, et al.
Clinical Pharmacology in Drug Development
|
July 18, 2022
Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B-Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein, in Healthy Chinese Subjects
Jing Xie, Xiaoyun Fan, Yue Su, et al.
Page
of 6